1 completed, 1 enrolling by invitation, 1 unknown. .
Follow CHC Montlegia: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Transmural Care for Chronically Ill Children: Scientific Guidance and Evaluation of Pilot Projects Pilot project paediatric transmural care - Chronic Diseases in Children, Chronic Diseases in Adolescence | Enrolling by invitation | University Hospital, Ghent | 1000 | 2024-09-10 | 2024-11-07 | |
| Daily Monitoring of Respiratory Symptoms and Spirometry During ETI Treatment in Persons With Cystic Fibrosis. Elexacaftor 100 MG / Ivacaftor 75 MG / Tezacaftor 50 MG, 2 tablets each morning + Ivacaftor 150 mg one tablet each evening - Cystic Fibrosis | Unknown | CHC Montlegia | 20 | 2022-09-01 | 2022-10-31 | |
| PAtient-PHYsician Relationship Assessment Questionnaire - Hepatocellular Carcinoma | Completed | Erasme University Hospital | 50 | 2021-04-05 | 2023-02-15 |
Carcinoma, Hepatocellular (1) · Chronic Disease (1) · Cystic Fibrosis (1) · Signs and Symptoms, Respiratory (1)
Surveys and Questionnaires (1) · elexacaftor (1) · ivacaftor (1) · tezacaftor (1)
Belgium (3)
Gontran Verset, MD (1) · Patrick Lebecque, PhD (1) · Veerle Duprez, dr. (1)